Reduced-dose Alemtuzumab for Kidney Transplant Rejection — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Reduced-dose Alemtuzumab for Kidney Transplant Rejection — Stella

Home/Kidney Transplant Rejection/

View on ClinicalTrials.gov

Recruiting

Back to Kidney Transplant Rejection trials

Trial locations(1 site)

Netherlands

Erasmus MC, Rotterdam, South Holland

Key details

Sponsor

Erasmus Medical Center

Enrollment target

~25 participants

Started

December 2023

Primary completion

July 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated February 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.